SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Doug Bean who wrote (1092)4/8/1999 7:41:00 AM
From: vestor  Read Replies (2) of 1837
 
Doug, Can we find out when the national advertising will begin? Do believe when it does a strong steady rise in DRMD share price will take place..... Would like to know of the lead time I have in order to accumulate shares before Cenestin becomes a household name..... Interesting news out this morn from Bloomberg.... they said studies have shown that Estrogen has been proven to improve memory capability in women.... perhaps this is now another indication that it would satisfy..... Notice that the article pits Duramed against AHP only.... Although it is understandable that the article suggests caution, there is a huge market for this product and there is enough room for two principal manufacturers...... realize too that a previously unknown mid range dosage has been given to Duramed to produce.... An effective marketing and advertising campaign should grap a sizeable market share and I would not be surprised at all if it exceeds 10% in the first year.... Given as well the 8 ANDA's before the FDA plus the recently others..... I see DRMD showing profitability in the late second half of this year.... Do we have any idea as the the profit margin and seliing price of Cenestin at this time ?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News